SIRT6 and colorectal carcinoma: In colorectal cancer (CRC) cells, MDL-811 enhances SIRT6-mediated histone H3 deacetylation (H3K9Ac, H3K18Ac, and H3K56Ac) and inhibits the proliferation of CRC cell lines and organoids derived from patients [45].